ABBV vs ZTS
By Alex · Tickerpine
AbbVie Inc. vs Zoetis Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | ZTS |
|---|---|---|
| Price | $295.03 | $83.82 |
| Market cap | $521.50B | $34.06B |
| P/E ratio | 50.7 | 14.3 |
| ROE | — | 57.63% |
| Profit margin | 15.67% | 26.41% |
| Revenue growth | 10.30% | -1.30% |
| Dividend yield | 2.35% | 2.53% |
| Beta | 0.19 | 0.68 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs ZTS in plain English
- ABBV is the bigger company — about 15.3× the market cap of ZTS.
- ZTS is cheaper on earnings (P/E 14.3 vs 50.7).
- ABBV is growing revenue faster (10% vs -1%).
- ZTS has the higher dividend yield (2.53% vs 2.35%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
ZTS return calculator
See what $1,000 in Zoetis Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.